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Abstract 
Background: Hemodialysis (HD) catheters are frequently inserted into the superior vena cava (SVC), and can lead to 
thrombotic complications. However, to our knowledge, HD catheter-related thrombosis leading to subsequent SVC 
syndrome, bacteremia, and pulmonary emboli has not been described.
Case presentation: A 28-year-old dialysis-dependent woman with IgA nephropathy developed facial swelling, head 
pressure, headache, nausea, dizziness and fever 6 weeks after right internal jugular (IJ) HD catheter placement. Chest 
and neck imaging demonstrated a non-occlusive thrombus surrounding the HD catheter and extending from the 
SVC to the junction of the right IJ and right subclavian veins, confirming thrombosis-associated SVC syndrome. Intra-
venous (IV) anticoagulation was initiated, as well as IV vancomycin for Staphylococcus epidermidis bacteremia. Despite 
prompt intravenous anticoagulation, 9 and 12 days after initial presentation she developed catheter-associated 
pulmonary embolism (PE) and PE-associated pulmonary infarction, respectively. Hypercoagulable workup was nega-
tive. The HD catheter was eventually replaced, HD resumed, and the patient was transitioned from intravenous to oral 
anticoagulation and discharged. Nine months later, she underwent successful renal transplantation.
Conclusion: SVC syndrome and pulmonary embolism are potential consequences of HD catheter-related thrombo-
sis. Given the frequency of HD catheter placement, physicians should be aware of these potential complications in 
any patient with HD catheter-related thrombosis.
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Background
In 2012, 61  % of patients with incident end-stage renal 
disease (ESRD) were initiated on hemodialysis (HD) via 
catheter alone (i.e., without a fistula or arteriovenous 
graft) [1]. When inserted into the lumen of the superior 
vena cava (SVC), these HD catheters have been shown 
to be associated with catheter-related thrombosis, SVC 
syndrome, bacteremia and thromboembolism [2–11]. 
However, to our knowledge, the co-occurrence of these 
complications in the setting of HD catheter placement 
has not been reported.
Case presentation
A 28-year-old Asian female hairstylist with hyperten-
sion and ESRD secondary to IgA nephropathy presented 
to an outside hospital with one week of facial swelling, 
head pressure that worsened when lying on the right 
side, headache when bending forward, nausea, dizzi-
ness and fever (Table 1). Six weeks prior to presentation, 
she initiated hemodialysis via a tunneled right internal 
jugular (IJ) HD catheter. Her substance use, social, and 
family history were unremarkable. Contrast-enhanced 
computed tomography (CT) of the chest and neck 
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performed on the day of admission demonstrated the 
HD catheter tip in the inferior right atrium, with throm-
bus formed around the HD catheter and extending along 
the catheter from the junction of the right IJ and right 
subclavian vein, through the SVC and to the level of the 
cavoatrial junction. In the setting of SVC thrombus, she 
was initiated on a continuous intravenous (IV) heparin 
infusion.
Based on blood cultures obtained on admission to the 
outside hospital (4 days prior to transfer to our hospital), 
the patient was found to have Staphylococcus epidermidis 
bacteremia, prompting initiation of IV vancomycin. 
Repeat blood cultures were negative. Since the thrombus 
was situated proximal to the catheter lumen, hemodialy-
sis was considered safe and continued without incident. 
Given the need for possible advanced interventions for 
the tunneled HD catheter, 4  days after admission she 
was transferred to our tertiary care hospital for further 
management.
Upon transfer, her vital signs were: temperature 
38.3 ℃, heart rate 96 beats per minute, blood pres-
sure of 134/61  mmHg, respiratory rate of 18 breaths 
per minute and oxygen saturation of 99 % on room air. 
Her physical exam was notable for diffuse facial swell-
ing and neck fullness. The heparin drip, vancomycin, 
analgesics and hemodialysis were continued. Warfarin 
was considered but held in anticipation of possible HD 
catheter replacement. A hypercoagulable workup was 
negative.
In the first 4  days at our hospital, the symptoms of 
SVC syndrome persisted despite continuous IV heparin, 
with worsening headache and facial pressure along with 
persistent fever despite negative blood cultures. Repeat 
contrasted CT of the chest demonstrated unchanged 
adherent, non-occlusive thrombus around the catheter 
without extension beyond the SVC (Figs.  1, 2). Phar-
macological thrombolysis was considered but not per-
formed in the setting of bacteremia, out of concern for 
bacterial shedding of a possibly infected clot (despite 
negative repeat blood cultures). Given the persistent 
thrombus-associated SVC syndrome with worsen-
ing headache and possibility of an infected thrombus 
with persistent fever, the interventional radiology team 
removed and replaced the right IJ HD catheter with-
out incident, using ultrasound- and fluoroscopy-guided 
methods. Using digital subtraction angiography (DSA) 
during fluoroscopy, an eccentric, adherent intraluminal 
thrombus measuring approximately 2 cm was visualized 
on the right lateral aspect of the SVC. After replacement 
Table 1 Timeline of clinical events
Time Event
Day 0 28yo woman with end-stage renal disease in the setting of IgA nephropathy undergoes right IJ 
tunneled HD catheter placed for initiation of hemodialysis
Day 47 Presents to outside hospital with SVC syndrome and started on intravenous heparin
Day 51 Transferred to our hospital with SVC syndrome and bacteremia (on IV heparin and IV vancomycin) 
for consideration of advanced interventions involving the HD catheter
Day 55 Due to the persistence of thrombus-associated SVC syndrome, HD catheter is removed and 
replaced; IV vancomycin and IV heparin are continued, and coumadin is initiated
Day 60 Develops right-sided chest pain with fever; CT angiography demonstrates R-sided pulmonary 
embolism
Day 63 Develops pleuritic chest pain with blood tinged sputum; CT chest demonstrates pulmonary infarc-
tion
Day 69 Resolution of symptoms; discharged with six-month course of coumadin, 28-day course of vanco-
mycin, and outpatient hemodialysis
Day 268 (approximately 9 months after discharge) Underwent renal transplant
Fig. 1 CT chest with contrast (transverse view) demonstrating an HD 
catheter (bright white shown by red arrow) with surrounding throm-
bus in the superior vena cava (blue arrow)
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of the HD catheter, both the IV heparin drip and vanco-
mycin along with analgesia were resumed, and warfarin 
was initiated. 
Nine days into admission and 5  days after new HD 
catheter replacement, the patient developed acute right-
sided pleuritic chest pain with high-grade fevers. Com-
puted tomography angiography (CTA) of the chest 
demonstrated an interval decrease in size of the SVC 
thrombus, along with new pulmonary embolism involv-
ing the right main, middle, and lower lobe pulmonary 
arteries (Fig.  3). Because the patient was hemodynami-
cally stable and had no signs of right ventricular dysfunc-
tion on transthoracic echocardiogram, thrombolysis was 
not considered. Regarding her fever, repeat blood cul-
tures were negative, lending suspicion to fever secondary 
to clot burden. However, out of concern for infected 
thrombus in a patient undergoing kidney transplant 
evaluation, vancomycin was continued based on a rec-
ommendation of the infectious disease team. The patient 
was therefore continued on continuous IV heparin, war-
farin, IV vancomycin, analgesics, and antipyretics.
Three days after the pulmonary embolism, the patient 
again developed pleuritic chest pain, but this time accom-
panied by blood-tinged sputum. A non-contrasted CT 
scan of the chest showed multifocal peripheral wedge-
shaped ground glass areas in the right lower and middle 
lobes, consistent with pulmonary infarction (Fig.  4). In 
the setting of a subtherapeutic international normalized 
ratio (INR) for prothrombin time (PT), both heparin and 
warfarin were continued. Once the INR reached thera-
peutic levels (goal range 2.0–3.0), the heparin infusion 
was discontinued.
Eighteen days after transfer to our hospital and 22 days 
after her initial hospital admission, the patient’s symp-
toms had remitted completely and she was discharged 
with prescriptions for a 6-month course of coumadin, 
completion of a 28-day course of vancomycin (starting 
from the day of her catheter removal), and oral pain med-
ications. Outpatient hemodialysis continued uneventfully 
through the new-tunneled HD catheter. Her INR was 
monitored closely with no adverse events noted. Nine 
months after discharge, she underwent successful renal 
transplantation.
Discussion
This case involved a young female patient who experi-
enced three particularly extreme complications of HD 
catheter-associated thrombosis: superior vena cava 
Fig. 2 CT chest with contrast (sagittal view) demonstrating catheter 
in the SVC (bright white shown by red arrow) with surrounding 
thrombus
Fig. 3 Computed tomography angiography (CTA) of the chest 
(transverse view) demonstrating thrombus in the right pulmonary 
artery (red arrow)
Fig. 4 CT chest without contrast (transverse view) demonstrating a 
right lower lobe wedge-shaped pulmonary infarction (red arrow)
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(SVC) syndrome, bacteremia and pulmonary embolism 
(PE). HD catheters, which are often inserted into the 
internal jugular vein, are predisposed to catheter-related 
thrombosis. As compared to other central venous cath-
eters (CVCs), it is believed that HD catheters may be 
associated with an increased risk of thrombosis-related 
complications, due to being used for hemodialysis, hav-
ing longer and thicker lumens, longer placement dura-
tion, and/or differences in blood flow, however this 
relationship is unknown. Similar to CVCs, risk factors 
for HD catheter-related thrombosis include catheter-
related characteristics including catheter caliber-to-vein 
ratio (i.e., 45  % or less associated with decreased VTE 
risk [12]), venipuncture-associated trauma (which can 
be reduced with ultrasound guidance [13]), and catheter 
position (i.e., higher risk if catheter tip is in the brachio-
cephalic vein or proximal SVC versus distal to SVC [14]), 
and patient-related characteristics including vein caliber, 
malignancy, prior thromboembolism, and a hypercoagu-
lable state [15]. The mechanism underlying HD catheter-
associated thrombosis is poorly understood, however 
factors such as recurrent vascular access, platelet dys-
function, endothelial factors, inflammation, and clotting 
abnormalities have been suggested [4].
While we could not be certain that our patient had a 
predisposing prothrombotic state, her history of IgA 
nephropathy and isolated proteinuria may have been 
associated with the thromboembolic event, given case 
reports suggesting an association of combined IgA 
nephropathy, malignancy, nephrotic syndrome, and 
heavy proteinuria with renal vein thrombosis, throm-
botic microangiopathy, left ventricular thrombus, and PE 
[16–19]. However, patients with isolated IgA nephropa-
thy, as compared to those with membranous nephropa-
thy (MN) or focal segmental glomerulosclerosis (FSGS), 
have been shown to have a relatively low risk of throm-
boembolism [16, 20]. Hence, given that our patient had 
proteinuria without nephrotic syndrome in the setting of 
IgA nephropathy, we were less sure that IgA nephropa-
thy played a substantial role, if any, in her development of 
HD catheter-related thrombosis.
Regarding the PE presented in this case, prior studies 
of thrombosed venous catheters have found pulmonary 
emboli pathologically similar to the thrombosis in the 
SVC [21, 22]. Additionally, thrombus dislodgement has 
been reported immediately following catheter removal 
using transesophageal echocardiographic imaging [23]. In 
this specific case, we theorized the patient’s PE occurred 
secondary to slow migration of thrombus off the catheter 
or SVC vessel wall, or to its dislodgement during HD cath-
eter removal, and not due to non-catheter-related throm-
bus formation. Given that our patient had a PE 5  days 
after HD catheter removal, it seems more likely that slow 
thrombus migration explained her PE more so than cath-
eter removal-related thrombus dislodgement. Neverthe-
less, we cannot be certain of the precise mechanism.
At this time, there are no published strategies regarding 
prevention of venous thrombosis and thromboembolism 
in patients with HD catheters. Large randomized con-
trolled trials (RCTs) involving prophylactic anticoagula-
tion for cancer patients with CVCs have been published, 
including a recent meta-analysis of nine RCTs demon-
strating unclear benefits and risks of thromboprophylaxis 
in this patient population. To our knowledge, trials in 
patients without cancer, such as the patient presented in 
this case, have not been performed [15, 24]. Until more 
data surface in this area, practitioners can continue to 
perform standard catheter care, including regular flush-
ing with heparin or saline to maintain patency, and con-
sideration of silicon- or polyurethane-based catheters 
instead of those made from polyethylene. However, these 
strategies may not necessarily be associated with lower 
thrombosis risk [25].
As per guidelines by the American College of Chest 
Physicians (ACCP), in the setting of catheter-associated 
upper extremity DVTs, catheters no longer required can 
be removed. Available data do not suggest use of antico-
agulation prior to catheter removal, but do recommend 
anticoagulation for 3  months following removal. How-
ever, when catheters are functional and required, they 
can remain in place, and anticoagulation should be con-
tinued for the duration of catheter placement [26]. Since 
we were not aware of the presence of an upper-extrem-
ity DVT in the above case, these guidelines do not 
specifically apply to our patient. Moreover, specific rec-
ommendations regarding catheter-related SVC or right 
atrial thrombosis with or without PE have not been 
published. In case reports and small studies involving 
patients similar to ours, anticoagulant therapy with low 
molecular weight heparin (in patients without ESRD) or 
unfractionated heparin has been administered, followed 
by an oral vitamin K antagonist [3, 15, 27, 28]. Finally, 
while systemic and catheter-directed thrombolysis 
along with stent placement have been used to success-
fully treat catheter-associated thrombosis and thrombo-
embolism, this evidence is limited to case reports and 
therefore requires further investigation [5, 6, 27].
In summary, our case of a 28-year old with IgA 
nephropathy who developed SVC thrombosis and sub-
sequent SVC syndrome and pulmonary embolism high-
lights an under-recognized complication of HD catheter 
placement. When a patient with an HD catheter devel-
ops signs and symptoms related to catheter-associated 
thrombosis, health care providers must be mindful of 
other potential subsequent complications, and consider 
prompt workup and treatment.
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Conclusion
Superior vena cava syndrome and pulmonary embo-
lism are potential consequences of hemodialysis cath-
eter-related thrombosis. Practitioners should monitor 
for these potentially life-threatening complications in 
any patient with an HD catheter who develops cath-
eter-related thrombosis. Given the increasing use of 
HD catheters, further investigation is needed to clarify 
the prevalence, pathophysiology, risk factors, prophy-
laxis and treatment for this potentially life-threatening 
complication.
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